

Strategic healthcare executive with 30 years of experience in mergers and acquisitions, corporate development, capital allocation, venture capital, and enterprise transformation across regulated healthcare markets in the United States and internationally. Proven track record leading full-cycle buy-side transactions, due diligence, transaction structuring, post-merger integration, operational restructuring, and value creation initiatives across multi-site clinical and technology-enabled healthcare platforms. Board-facing executive with direct accountability for P&L leadership, EBITDA improvement, regulatory risk management (CMS, OIG, DOJ), investor relations, and governance oversight.